JP Stock MarketDetailed Quotes

4551 Torii Pharmaceutical

Watchlist
  • 4680
  • +340+7.83%
20min DelayNot Open Apr 30 15:30 JST
134.78BMarket Cap26.09P/E (Static)

Torii Pharmaceutical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
Total revenue
9.16%14.68B
10.59%60.43B
6.98%14.86B
13.89%13.45B
11.75%54.64B
15.51B
9.99%13.43B
14.38%13.89B
7.76%11.81B
4.06%48.89B
Cost of revenue
7.64%8.06B
12.97%33.72B
9.78%8.21B
19.07%7.49B
16.97%29.85B
8.75B
15.49%7.33B
17.35%7.48B
10.84%6.29B
12.66%25.52B
Gross profit
11.09%6.62B
7.73%26.71B
3.72%6.64B
7.99%5.96B
6.04%24.79B
6.76B
4.06%6.11B
11.12%6.41B
4.44%5.52B
-3.94%23.38B
Operating expense
7.38%4.92B
0.79%19.91B
9.58%4.89B
-23.15%4.58B
10.74%19.75B
4.93B
-1.78%4.41B
1.90%4.46B
49.25%5.96B
-9.38%17.83B
Staff costs
4.47%1.26B
-2.85%5.01B
-7.58%1.26B
-3.97%1.21B
1.88%5.16B
--1.32B
3.04%1.22B
10.49%1.36B
0.40%1.26B
0.56%5.07B
Selling and administrative expenses
43.71%480M
17.57%4.25B
-8.08%364M
-11.41%334M
9.95%3.62B
--2.45B
-2.51%388M
14.78%396M
22.40%377M
-21.47%3.29B
-Selling and marketing expense
43.71%480M
23.89%1.96B
-8.08%364M
-11.41%334M
0.06%1.58B
--421M
-2.51%388M
14.78%396M
22.40%377M
-62.24%1.58B
-General and administrative expense
----
12.64%2.29B
----
----
19.10%2.03B
----
----
----
----
--1.71B
Research and development costs
27.26%677M
-19.08%2.82B
133.43%831M
-74.14%532M
110.11%3.49B
--679M
-21.34%398M
-12.53%356M
1,068.75%2.06B
99.64%1.66B
Depreciation and amortization
----
-7.34%202M
----
----
-6.84%218M
----
----
----
----
-9.65%234M
-Depreciation
----
-7.34%202M
----
----
-6.84%218M
----
----
----
----
-9.65%234M
Other operating expenses
-0.28%2.5B
4.82%7.62B
3.71%2.43B
10.55%2.5B
-4.21%7.27B
--256M
0.08%2.4B
-1.92%2.35B
0.49%2.27B
-18.99%7.59B
Operating profit
23.34%1.71B
34.91%6.8B
-9.70%1.76B
417.43%1.38B
-9.09%5.04B
1.83B
22.99%1.7B
40.14%1.95B
-133.67%-436M
19.02%5.55B
Net non-operating interest income (expenses)
50.67%113M
24.39%357M
13.89%82M
20.97%75M
71.86%287M
75M
73.33%78M
157.14%72M
63.16%62M
15.97%167M
Non-operating interest income
50.67%113M
24.39%357M
13.89%82M
20.97%75M
71.86%287M
--75M
73.33%78M
157.14%72M
63.16%62M
15.97%167M
Non-operating interest expense
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Net investment income
189.80%44M
127.27%25M
74.63%-17M
-188.24%-49M
-15.38%11M
97M
-106.67%-2M
-63.41%-67M
74.63%-17M
-82.89%13M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
95.02%-12M
-196.39%-267M
0.00%-9M
-1,168.42%-241M
121.60%277M
314M
35.71%-9M
-105.20%-9M
0.00%-19M
226.26%125M
Income from associates and other participating interests
Special income (charges)
16.67%-5M
-455.56%-200M
-100.00%-2M
-500.00%-6M
-1,700.00%-36M
-34M
0
-1M
-1M
94.87%-2M
Less:Other special charges
-16.67%5M
455.56%200M
100.00%2M
500.00%6M
1,700.00%36M
--34M
--0
--1M
--1M
-92.59%2M
Other non-operating income (expenses)
650.00%11M
-40.00%12M
0.00%5M
-133.33%-2M
116.53%20M
4M
-16.67%5M
103.60%5M
500.00%6M
-503.33%-121M
Income before tax
60.26%1.86B
20.24%6.73B
-6.63%1.82B
386.42%1.16B
-2.25%5.59B
2.28B
22.21%1.77B
38.04%1.95B
-132.50%-405M
20.03%5.72B
Income tax
64.41%462M
14.19%1.68B
-16.70%474M
342.24%281M
-17.15%1.47B
529M
11.85%491M
27.58%569M
-131.87%-116M
27.73%1.78B
Net income
58.43%1.39B
22.41%5.04B
-2.26%1.34B
404.86%878M
4.44%4.12B
1.75B
26.81%1.28B
42.68%1.37B
-132.65%-288M
16.89%3.94B
Net income continuous operations
58.93%1.4B
22.40%5.04B
-2.47%1.34B
404.15%879M
4.46%4.12B
--1.75B
26.71%1.28B
42.89%1.38B
-132.77%-289M
16.86%3.94B
Noncontrolling interests
Net income attributable to the company
58.43%1.39B
22.41%5.04B
-2.26%1.34B
404.86%878M
4.44%4.12B
1.75B
26.81%1.28B
42.68%1.37B
-132.65%-288M
16.89%3.94B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
58.43%1.39B
22.41%5.04B
-2.26%1.34B
404.86%878M
4.44%4.12B
1.75B
26.81%1.28B
42.68%1.37B
-132.65%-288M
16.89%3.94B
Gross dividend payment
Basic earnings per share
58.33%49.51
22.36%179.38
-2.43%47.77
404.18%31.27
4.42%146.6
62.33
26.74%45.59
42.78%48.96
-132.74%-10.28
16.87%140.39
Diluted earnings per share
58.33%49.51
22.36%179.38
-2.31%47.77
404.18%31.27
4.42%146.6
62.3016
26.74%45.59
42.65%48.8985
-132.74%-10.28
16.87%140.39
Dividend per share
0
0.00%120
20.00%60
0
20.00%120
70
0
108.33%50
0
108.33%100
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022
Total revenue 9.16%14.68B10.59%60.43B6.98%14.86B13.89%13.45B11.75%54.64B15.51B9.99%13.43B14.38%13.89B7.76%11.81B4.06%48.89B
Cost of revenue 7.64%8.06B12.97%33.72B9.78%8.21B19.07%7.49B16.97%29.85B8.75B15.49%7.33B17.35%7.48B10.84%6.29B12.66%25.52B
Gross profit 11.09%6.62B7.73%26.71B3.72%6.64B7.99%5.96B6.04%24.79B6.76B4.06%6.11B11.12%6.41B4.44%5.52B-3.94%23.38B
Operating expense 7.38%4.92B0.79%19.91B9.58%4.89B-23.15%4.58B10.74%19.75B4.93B-1.78%4.41B1.90%4.46B49.25%5.96B-9.38%17.83B
Staff costs 4.47%1.26B-2.85%5.01B-7.58%1.26B-3.97%1.21B1.88%5.16B--1.32B3.04%1.22B10.49%1.36B0.40%1.26B0.56%5.07B
Selling and administrative expenses 43.71%480M17.57%4.25B-8.08%364M-11.41%334M9.95%3.62B--2.45B-2.51%388M14.78%396M22.40%377M-21.47%3.29B
-Selling and marketing expense 43.71%480M23.89%1.96B-8.08%364M-11.41%334M0.06%1.58B--421M-2.51%388M14.78%396M22.40%377M-62.24%1.58B
-General and administrative expense ----12.64%2.29B--------19.10%2.03B------------------1.71B
Research and development costs 27.26%677M-19.08%2.82B133.43%831M-74.14%532M110.11%3.49B--679M-21.34%398M-12.53%356M1,068.75%2.06B99.64%1.66B
Depreciation and amortization -----7.34%202M---------6.84%218M-----------------9.65%234M
-Depreciation -----7.34%202M---------6.84%218M-----------------9.65%234M
Other operating expenses -0.28%2.5B4.82%7.62B3.71%2.43B10.55%2.5B-4.21%7.27B--256M0.08%2.4B-1.92%2.35B0.49%2.27B-18.99%7.59B
Operating profit 23.34%1.71B34.91%6.8B-9.70%1.76B417.43%1.38B-9.09%5.04B1.83B22.99%1.7B40.14%1.95B-133.67%-436M19.02%5.55B
Net non-operating interest income (expenses) 50.67%113M24.39%357M13.89%82M20.97%75M71.86%287M75M73.33%78M157.14%72M63.16%62M15.97%167M
Non-operating interest income 50.67%113M24.39%357M13.89%82M20.97%75M71.86%287M--75M73.33%78M157.14%72M63.16%62M15.97%167M
Non-operating interest expense --0--0--0--0--0--0--0--0--0--0
Net investment income 189.80%44M127.27%25M74.63%-17M-188.24%-49M-15.38%11M97M-106.67%-2M-63.41%-67M74.63%-17M-82.89%13M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets 95.02%-12M-196.39%-267M0.00%-9M-1,168.42%-241M121.60%277M314M35.71%-9M-105.20%-9M0.00%-19M226.26%125M
Income from associates and other participating interests
Special income (charges) 16.67%-5M-455.56%-200M-100.00%-2M-500.00%-6M-1,700.00%-36M-34M0-1M-1M94.87%-2M
Less:Other special charges -16.67%5M455.56%200M100.00%2M500.00%6M1,700.00%36M--34M--0--1M--1M-92.59%2M
Other non-operating income (expenses) 650.00%11M-40.00%12M0.00%5M-133.33%-2M116.53%20M4M-16.67%5M103.60%5M500.00%6M-503.33%-121M
Income before tax 60.26%1.86B20.24%6.73B-6.63%1.82B386.42%1.16B-2.25%5.59B2.28B22.21%1.77B38.04%1.95B-132.50%-405M20.03%5.72B
Income tax 64.41%462M14.19%1.68B-16.70%474M342.24%281M-17.15%1.47B529M11.85%491M27.58%569M-131.87%-116M27.73%1.78B
Net income 58.43%1.39B22.41%5.04B-2.26%1.34B404.86%878M4.44%4.12B1.75B26.81%1.28B42.68%1.37B-132.65%-288M16.89%3.94B
Net income continuous operations 58.93%1.4B22.40%5.04B-2.47%1.34B404.15%879M4.46%4.12B--1.75B26.71%1.28B42.89%1.38B-132.77%-289M16.86%3.94B
Noncontrolling interests
Net income attributable to the company 58.43%1.39B22.41%5.04B-2.26%1.34B404.86%878M4.44%4.12B1.75B26.81%1.28B42.68%1.37B-132.65%-288M16.89%3.94B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 58.43%1.39B22.41%5.04B-2.26%1.34B404.86%878M4.44%4.12B1.75B26.81%1.28B42.68%1.37B-132.65%-288M16.89%3.94B
Gross dividend payment
Basic earnings per share 58.33%49.5122.36%179.38-2.43%47.77404.18%31.274.42%146.662.3326.74%45.5942.78%48.96-132.74%-10.2816.87%140.39
Diluted earnings per share 58.33%49.5122.36%179.38-2.31%47.77404.18%31.274.42%146.662.301626.74%45.5942.65%48.8985-132.74%-10.2816.87%140.39
Dividend per share 00.00%12020.00%60020.00%120700108.33%500108.33%100
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP